These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26566627)

  • 1. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
    Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
    Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
    Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
    Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
    Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
    Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
    Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
    Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
    World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
    Si Y; Zhang H; Ning T; Bai M; Wang Y; Yang H; Wang X; Li J; Ying G; Ba Y
    Cell Physiol Biochem; 2017; 42(4):1670-1683. PubMed ID: 28738343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
    World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.
    Shen Z; Yan Y; Ye C; Wang B; Jiang K; Ye Y; Mustonen H; Puolakkainen P; Wang S
    Tumour Biol; 2016 Jun; 37(6):7267-76. PubMed ID: 26666821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer.
    Lee Y; Kim SJ; Choo J; Heo G; Yoo JW; Jung Y; Rhee SH; Im E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.
    Chen H; Li L; Wang S; Lei Y; Ge Q; Lv N; Zhou X; Chen C
    Oncotarget; 2014 Dec; 5(23):11873-85. PubMed ID: 25428912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
    Roy R; Dagher A; Butterfield C; Moses MA
    Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
    Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
    Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of RELM-α correlates with poor prognosis and promotes angiogenesis in gastric cancer.
    Chen P; Zhao D; Wang W; Zhang Y; Yuan Y; Wang L; Wu Y
    Oncol Rep; 2015 Jul; 34(1):77-86. PubMed ID: 25937206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
    Sun P; Yu H; Zhang WQ; Hu M; Lv R
    Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR‑20b negatively regulates VEGF expression by targeting STAT3 in H22 hepatocellular carcinoma cells.
    Luo Y; He J; Tao X; Wang H; Fang Q; Guo S; Song C
    Oncol Rep; 2018 Nov; 40(5):2806-2813. PubMed ID: 30132576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.